В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …

Background Patients with antibody deficiency respond poorly to coronavirus disease 2019
(COVID-19) vaccination and are at risk of severe or prolonged infection. They are given long …

Abstract Introduction/Aims In this study we investigated COVID‐19 vaccination–related
adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory …

COVID-19 has been spreading worldwide since late 2019. There is no definitive cure to
date. Global vaccination programs are urgently required to confer herd immunity, reducing …

Objective The development of sufficient COVID-19 vaccines has been a big breakthrough in
fighting the global SARS-CoV-2 pandemic. However, vaccination effectiveness can be …

Abstract Coronavirus disease 2019 (COVID-19) is a real challenge for humanity with high
morbidity and mortality. Despite being primarily a respiratory illness, COVID-19 can affect …

Background There is a necessity for an optimal COVID-19 vaccination strategy for
vulnerable population groups, including people with autoimmune inflammatory arthritis on …

Objectives To evaluate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine acceptance among patients with rheumatic diseases (RMD). Methods All …

Importance B-cell–depleting monoclonal antibodies are widely used for treatment of multiple
sclerosis but are associated with an impaired response to vaccines. Objective To identify …

Although COVID-19 outcomes have improved over the pandemic for patients with RA, some
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …